CPT code 94644 represents administration of inhalation aerosol medication for up to one hour to treat acute airway obstruction. Nationally, this code captures a time-based, clinician-directed respiratory intervention commonly used in emergency and acute care settings to reverse bronchospasm, improve ventilation, and stabilize patients with obstructive respiratory events. It is important for claims accuracy and appropriate care documentation because it reflects direct therapeutic intervention in potentially life-threatening situations.

Key payers covered in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find clinical context for use of the code, typical sites of service where it is billed, and insights into common billing considerations. The publication outlines benchmarks where available, summarizes relevant policy themes that affect coverage and reimbursement for acute inhalation therapies, and clarifies documentation elements that support appropriate coding. Data not available in the input will be explicitly noted where relevant. This summary is tailored for a national audience of coding professionals, clinicians, and policy analysts seeking a concise reference on CPT code 94644 and its role in acute respiratory care.